mediators of protection in scrub typhus infection of mice or whether they served to recruit the host's own defenses, or both. However, it was possible to conclude that PEL's and SpLs exhibited functional heterogeneity and that PELs were more efficient mediators of protection.
In a recent report, we assessed the relative contributions of cellular and humoral immunity in experimental scrub typhus infection of mice (7) by employing Rickettsia tsutsugamushi strains differing in virulence for mice (2) . Infection with the less virulent Gilliam strain resulted in heterologous protection against an otherwise lethal challenge of the virulent Karp strain. Furthermore, it was shown that significant protection was afforded by the passive transfer of spleen cells and that the protective lymphoid cell in the splenic material transferred was a thymus-dependent lymphocyte (7) .
During these transfer studies, both the immune cells and challenge infection were given intraperitoneally (i.p.). Consequently, the study established only that the spleen contained antigen-reactive cells capable of conferring protection and did not provide information as to whether the spleen cells were, in fact, the prox-imate or direct mediators of cellular immunity in the physiological situation. Exhaustive studies by McGregor and his colleagues (3) (4) (5) (6) have indicated that peritoneal exudate lymphocytes are the physiological mediators of cellular immunity in other bacterial diseases. These studies led us to explore the possibility that in mice peritoneal exudate lymphocytes are also the physiological mediators responsible for immunity to heterologous scrub typhus infection. Specifically, we examined the protection elicited against heterologous rickettsial challenge by both spleen and peritoneal exudate lymphocytes administered either i.p. or intravenously (i.v.); assessed the temporal resistance to gamma radiation of lymphocytes obtained from both spleen and peritoneum; and finally, determined the effect of peritoneal exudate induction on the protective capacity of lymphocytes resident in the spleen.
MATERIALS AND METHODS
Animals. Female BALB/c mice (Flow Laboratories, Dublin, Va.), 18 to 22 g, were used throughout the study.
Scrub typhus strains. The Karp and Gilliam strains of R. tsutsugamushi were propagated and stored, and the 50% mouse infective dose (MIDso) and the 50% mouse lethal dose (MLD5o) were determined as previously described (1) .
Preparation of spleen cells. Donor mice to be used for cell transfer studies were killed by cervical dislocation. Spleens were removed aseptically and minced. Fragments were pressed through a stainlesssteel, 60-mesh screen into a plastic petri dish (60 by 15 
RESULTS
Experimental design. The contribution of various lymphoid cell populations to host protection was evaluated by a series of cell transfer experiments in which the following protocol was used. Mice were immunized by a single i.p. inoculation of 100 MLD50 of R. tsutsugamushi Gilliam. As reported previously, animals tolerated this procedure well and few mice died (7) . At various days after inoculation, 5 to 50 animals were sacrificed, their spleens and/or peritoneal exudate cells were removed aseptically, and appropriate single-cell, lymphocyte-rich suspensions were prepared as detailed above. The cell concentration was adjusted to 30 x 106 lymphocytes per 0.2 ml, since i.p. inoculation of this number of splenic lymphocytes had previously been shown to provide complete protection against i.p. challenge (7). Cells were injected either i.p. or i.v. as required by the experiment, and recipient animals were challenged i.p. 8 h later with 1,000 MLD50 of the Karp strain. The results were expressed as the percentage of ultimate survivors in each group of 10 or more animals.
Comparison of the protection achieved by i.p. transfer of immune SpL's and PELs. In general, the protection afforded by transfer of SpL's was quite similar to that previously reported (7) and is summarized in Fig. 1 18, 1977 i.v. were much less effective at early times in protecting against lethal challenge (Fig. 2) . Thus, whereas an i.p. transfer of 7-day immune SpL's achieved 80% protection (Fig. 1) , a comparable i.v. transfer of these cells resulted in only 20% protection (Fig. 2) . At 14 days postimmunization, total protection could be achieved by the transfer of immune SpL's regardless of the route ( Fig. 1 and 2) . However, whereas the protection afforded by i.p. transfers of immune SpL's plateaued at these high levels for a few weeks (Fig. 1) , that afforded by SpL's given i.v. rapidly declined to low levels after day 14 (Fig.   2) .
The weak protective response elicited by the 2) , and surviving mice all showed signs of illness. There were differences in protection between i.v. and i.p. PEL transfers. However, these were less striking than the comparable experiments with SpL's. The complete protection seen with i.p. transfer of PELs at 7 days (Fig. 1) was delayed 1 week when transfers of similar immune lymphocytes were given i.v. (Fig. 2) . Complete protection, once achieved at day 14, plateaued until 28 days (Fig. 2) (Fig. 1) , i.v. protection declined at day 35, at which time the experiment was terminated (Fig. 2) .
Radiation sensitivity of the protective effects of immune SpL's and PELs given by i.p. transfer. The effect of in vitro irradiation (1,200 rads) on the protection offered by passively transferred (i.p.) SpL's was studied (Fig.  3) . In this experiment the protective effects of 30 x 106 untreated or in vitro irradiated immune SpL's were compared. Early in the course of immunization (i.e., at 7 and 10 days), relatively radiation-resistant populations of SpL's affording 90 and 50% survival, respectively, were demonstrated. At all other times, exposure to gamma radiation in vitro before transfer abolished the protective capacity of immune SpL's. It was interesting that the peak of radiation-resistant protection occurred before nonirradiated SpL's (given i.p.) were able to afford complete protection from mortality and morbidity (Fig. 3) .
A similar early (8-to 14-day) radiation-resistant population was seen with gamma-irradiated PELs (Fig. 4) . In contrast to the SpL's, this radiation resistance occurred after the time at which unirradiated PELs were able to afford complete protection. and followed with an i.p. lethal infectious challenge of scrub typhus rickettsiae (7). It was not clear whether SpL's participated in the immune response in vivo, particularly in view of histological evidence implicating PELs as mediators of cellular protection against scrub typhus rickettsiae (1) and of considerable data supporting the role of PELs as mediators of cellular immunity in other bacterial infections (3) (4) (5) (6) .
DISCUSSION
This study suggests that, whereas SpL transfer represents a valid assay for cell-mediated immunity against R. tsutsugamushi, PELs On the other hand, the later-appearing radiation-resistant PELs evidenced a short period of complete protection. These irradiation experiments were not comparable to the vinblastine studies described by Lefford et al. (5) and McGregor and Logie (6) concerning the protective capacity of lymphoid cells. In these latter experiments, the antimitotic drug was given in vivo and clearly affected such important aspects of cell-mediated protection as the ability of immune cells to enter an infectious focus. The fact that we administered irradiated cells i.p. circumvented any impairment in cellular circulation. A possible explanation for radiation resistance is the existence at that time of a large number of antigen-reactive cells, which obviate the need for division or clonal expansion. Other explanations, including radiation-resistant small lymphocytes capable of recruiting the host's immune response, must also be considered. Our data are insufficient for further speculation on the nature of this phenomenon, and the experiments were designed solely to compare the functional properties of the two populations.
The data presented here also caution against considering either protective PELs or SpL's as being functionally equivalent during all periods of rickettsial infection. Clearly, the splenic population is temporally heterogeneous with respect to ability to transfer protection by the i.v. route, and lymphocytes from both spleen and peritoneal exudate show temporal differences in radiation resistance. Further evidence for heterogeneity among immuncompetent lymphocytes was seen in experiments in which SpL's used for i.p. transfer were obtained from animals in which a peritoneil exudate was induced by injection of mineral oil. Early in the course of infection only a slight reduction in the protection transferred by SpLs was noted, but at later times (28 days) the induction of such an exudate totally abolished the protective capacity of SpL's. Even more striking results were observed with i.v. transfer, since only a brief and weakly protective capacity of SpL's withstood the concomitant peritoneal exudate. These data indicated that a portion of the spleen cells mediating protection were "mobilizable." The mechanism for depletion of lymphocytes from the spleen by a remote exudate is not well understood. Perhaps a portion of the protective cells are mobilized into the exudate itself and, therefore, are identical with PELs. Alternatively, a phenomenon of negative lymphoid trapping, as described by Zatz and Gershon (9) , may have been operative in excluding immunocompetent lymphocytes from the spleen.
We recognize the possibility that induction of suppressor cells may have influenced the differences in protection observed after transfer of immune PELs or SpL's, and this phenomenon is currently under investigation in our laboratory. The function of the protective cell, whether PEL or SpL, was not defined in this study. It may be that these cells represent the immediate effector cells that interact with macrophages or they may function to recruit the host's own immune response. Whatever the mechanism, the data presented here clearly indicate the heterogeneity of such cells and accentuate the need for further studies to more clearly define the physiological role of immunocompetent lymphocytes in rickettsial infection.
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